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Background: Acute Fibrinous and Organizing Pneumonia is a rare entity characterized by the histological pattern
suggestive of diffuse alveolar damage, eosinophilic pneumonia and organizing pneumonia; the presence of intra
alveolar “fibrin balls” distinguishes it from these conditions. Herein, we describe the association of acute fibrinous
and organizing pneumonia with a respiratory tract infection. We believe that such an association has been extremely
rarely described.
Case presentation: We report the case of a 68 year old female patient of Afghan descent who presented with
shortness of breath, cough and high grade fever not responding satisfactorily to standard antibiotic therapy.
Imaging revealed bilateral basilar infiltrates and ground glass opacification of the right lower lung zone. Though
the inflammatory markers decreased with antibiotic therapy, there was minimal improvement in the patient’s
symptoms and radiological appearance of the lungs. Bronchoscopy was refused by the patient’s family and a
Computed Tomography guided biopsy of the lung revealed a histological diagnosis of acute fibrinous and
organizing pneumonia. Patient was initiated on high dose intravenous corticosteroid therapy followed by a
maintenance dose of prednisolone at 40 mg/day. She recovered dramatically. However, due to poor compliance
with treatment, she relapsed and was re-treated with the same regimen. Currently she is completely symptom
free and is on a tapering corticosteroid dose.
Conclusion: We conclude that AFOP may be a rare but under diagnosed entity and recommend that it should
be considered in the differentials of a suspected pulmonary infection unresponsive to optimum antibiotic therapy.
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Acute Fibrinous and Organizing Pneumonia (AFOP)
was first described by Beasely et al. in 2002 as a distinct
pattern of lung injury with histological analogy to diffuse
alveolar damage, organizing pneumonia and eosinophilic
pneumonia. The features that distinguish it histologically
include intra alveolar fibrin balls, absence of typical
hyaline membranes and eosinophils, and numerous foci
of fibroblastic activity [1]. It has been described in all* Correspondence: zain.u.abideens@gmail.com
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article, unless otherwise stated.age groups with numerous associations including connective
tissue and autoimmune diseases, drugs, occupational and
environmental exposures, and less commonly infectious
agents. Occasionally, no cause has been found [2].
The signs and symptoms are variable; two forms of the
illness have been described; a severe form which leads to
a rapid respiratory failure and a sub acute form, which
has a good prognosis with treatment [1]. Diagnosis is by
histological analysis of a biopsy obtained from the affected
pulmonary tissue. There are no standard guidelines on
treatment; steroids and immunosuppressants have been
used with varying success rates, with best results in the subCentral. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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necessary for severe disease and carries poor prognosis.
We present the case of an elderly female patient who
presented to us with signs, symptoms, laboratory param-
eters and radiological features of typical community
acquired pneumonia (CAP) not responding adequately
to optimum antibiotic therapy. Though her symptoms
improved mildly and inflammatory markers normalized,
she never achieved her baseline status. A lung biopsy was
thus performed which revealed AFOP. The disease was of
the sub acute variety and responded well to steroids. She
relapsed a few weeks later due to poor compliance with
the treatment, however after readmission and retreatment
she improved rapidly.
To the best of our knowledge this is the twenty fourth
case report on AFOP and the first to be reported from
Pakistan and South Asia; moreover our search reveals it
to be the 8th case associated with a suspected pulmonary
infection.
Case presentation
A 68 years old female of Afghan descent with a past
medical history significant for controlled type 2 diabetes
mellitus, spinal stenosis due to which she was bed ridden
and recent upper respiratory tract infection presented
to the emergency department with progressively wors-
ening shortness of breath, high grade continuous feverFigure 1 Chest Radiographs during the first admission. Panel A shows
with soft tissue infiltrates noted in the right basal lung. There is also soft tissue
angles appear hazy. Panel B shows the X-ray after a week of antibiotic therapy
space shadowing in the right lower lung zone. Right costophrenic angle
of corticosteroid therapy. There is interval resolution of right lower lobe oassociated with rigors and chills, and a cough productive
of thick whitish sputum for 2 weeks. She had received 2
courses of antibiotics from a general practitioner without
relief.
She did not smoke and had no respiratory or cardiac
disease. She had a family history of ischemic heart disease
and her sister had recently been treated for pulmonary
tuberculosis.
On examination, she was an elderly lady in distress. Her
pulse rate was 110/minute, blood pressure 110/70 mm hg,
temperature 102 degrees Fahrenheit (°F) and respiratory
rate 30/minute. Her oxygen saturation was 92% on room
air. The percussion note was dull over the right lower lung
zone. On auscultation, air entry was decreased in the right
lower lung zone with bilateral coarse pan inspiratory crep-
itations and increased vocal resonance audible up to the
middle lung zones.
Arterial Blood gases revealed a pH of 7.44, partial pres-
sure of oxygen (pO2) 88 mm hg, partial pressure of carbon
dioxide (pCO2) 33 mm hg, bicarbonate 22 meq/L and
oxygen saturation 93%.
A chest X-ray revealed an inhomogeneous opacification
in the right basal lung with slight volume loss accompanied
by alveolar and interstitial infiltrates (Figure 1A). The white
blood cell count was 30,900 cells/mm3 (differentials 90%
neutrophils), C reactive protein (CRP) level 294 mg/dL and
the Erythrocyte Sedimentation Rate (ESR) was 65 mm/hr.the chest X-ray on presentation. There is an inhomogeneous opacification
opacification and haziness in the left lung lower zone. Both costophrenic
. There is interval increase in homogenous haze representing air
is intervally more blunt. Panel C shows the chest x ray after a week
pacity. The rest of the findings are unchanged.
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the normal respiratory tract flora. Three consecutive sam-
ples for Acid Fast Bacilli (AFB) were also negative. There
was no other identifiable source of infection in the body.
Autoimmune work up including anti nuetrophil anti-
body (ANA), anti nuetrophil cytoplasmic antibody (ANCA),
and rheumatoid factor (RF) were all negative.
The patient scored 2/5 on the CURB65 scoring system
for community acquired pneumonia and needed hospital
admission. She was initially treated with moxifloxacin
400 mg intravenously once daily and intravenous fluids.
Serial White cell counts and CRP levels showed resolution
with antibiotic therapy; however the patient’s complaints
improved minimally. Serial Chest X rays showed no sig-
nificant resolution of the right lower lung zone opacity
(Figure 1B).
A High resolution computed tomography scan (HRCT)
was performed 4 days after antibiotic therapy. It revealed
soft tissue nodular infiltrates and dense consolidation in
the lower lobe of the right lung. There was ground glass
opacification and haze bilaterally with more prominenence
in the right lower lobe (Figure 2). Atelactatic changes wereFigure 2 High Resolution computed tomography scan of the
chest. Panel A and B show soft tissue nodular infiltrates and dense
consolidation in the right lower lobe of the lung. There is ground
glass opacification and haze bilaterally with more prominenence in
the right lower lobe. Atelactatic changes are also present right middle
lobe, ligular segment and left lower lobe. There is pleural thickening
bilaterally and calcified pleural plaques are noted along the
diaphragmatic pleura on the left.also present right middle lobe, ligular segment and left
lower lobe. There was pleural thickening bilaterally and cal-
cified pleural plaques were noted along the diaphragmatic
pleura on the left. Our experienced radiologist described
these changes were most probably due to chronic infective/
granulomatous disease, most probably tuberculosis (TB). In
high suspicion of tuberculosis, especially since the patient
was not recovering, had a family history of treated TB in
the past one year and since TB is extremely common in
our country, anti tuberculous therapy (ATT) was begun
empirically.
Despite ATT, patient did not improve. A bronchosp-
copy was refused by the patient’s family. Thus finally a CT
guided biopsy of the right lower lung lobe was planned on
the 8th hospital admission day. Histopathology revealed
multiple organizing “fibrin balls” within alveolar spaces
without associated hyaline membrane formation. Variable
areas of spindle cells fibroblastic proliferation were also
seen with focal type II pneumocyte hyperplasia. Special
stains for fungus, Acid Fast Bacilli (AFB) and gram stain-
ing were all negative. There was no growth on culture of
the biopsied tissue. These changes are well depicted in
Figure 3.
Thus, finally with a diagnosis of acute fibrinous and
organizing pneumonia we started methyl prednisolone
60 mg/kg intravenously every six hours. There was a
dramatic and excellent response. Patient was discharged
after 10 days on oral prednisolone 40 mg daily; at this
point she was clinically much better, and very high doses
of steroids were avoided due to already severe osteopor-
osis. Figure 1C shows the interval improvement of the
chest x ray findings with this treatment.
One month later she presented again with shortness of
breath and non productive cough. She admitted to have
stopped taking steroids for the past 10 days. After read-
mission she was discharged on the same dose of pred-
nisolone with strict advice of adherence to steroids. Her
chest radiographs on this admission and discharge are
shown in Figure 3. On the next follow up 1 month later,
she was completely symptom free. Currently she is on a
tapering dose of steroids and is being evaluated by a
neurosurgeon for correction of her spinal stenosis. Over
all she tolerated the treatment well and complied well
after her first exacerbation.
Discussion
AFOP was first reported in detail in a retrospective
analysis of 17 case reports in 2002 [1]. Our search on
PubMed revealed 23 cases reported since then of which
3 described AFOP in children and neonates. Qui YY
et al. have published a review of 5 cases that were ana-
lyzed retrospectively as well [3].
AFOP has been reported in all age groups with an aver-
age age of 62 years originally described by Beasely et al.
Figure 3 Chest radiographs during the second admission. Panel A shows the radiograph after non compliance to corticosteroid therapy. There is
development of right lung haziness and bilateral pleural effusions with a right lower zone consolidation patch. Panel B shows the radiograph on
discharge after re treatment with corticosteroids. There is interval resolution of patchy lower zone lung infiltration which was more marked on the
right. Improved aeration of the lung is noted.
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adults [4-6]. Males are affected more commonly [1]. Our
patient was an elderly female.
AFOP can present with a variety of signs and symptoms.
The most common symptom is shortness of breath which
may be accompanied by cough, fever, hemoptysis and
other constitutional symptoms [1,6]. Two variants of the
disease have been described. A sub acute variety, which
does not progress to respiratory failure and has a very
good prognosis [1,6]. Our patient suffered from this vari-
ant which had an excellent response to corticosteroids.
The other variant usually manifests as a fulminant respira-
tory failure requiring mechanical ventilation. Mechanical
ventilation is associated with worse prognosis in AFOP
[1,6-8]. On average, severe disease usually causes death
within 29 days from symptom onset [1].
AFOP has been described with numerous conditions
in the past while twelve reported cases were idiopathic.
Some known associations include ankylosing spondylitis,
dermatomyositis, polymyositis, undifferentiated connect-
ive tissue diseases, SLE with antiphospolipid syndrome,
most recently anti synthetase syndrome and primary
biliary cirhosis [1,5,9-12]. Thus, there might be a strong
association between autoimmune disease and AFOP
[13]. There has been a case reported in a patient follow-
ing bone marrow transplant for acute myelogenous
leukemia [6]. Drugs implicated in AFOP include abaca-
vir, amoidarone and decitabine [6,14].
AFOP has also been reported with infective etiologies in-
cluding Hemophilus Influenza, Acinetobacter Baumannii
and Histoplasma species [1]. Otto et al. reported H1N1
causing AFOP in a patient with bilateral lung transplant-
ation. Human immune deficiency virus (HIV) alone and in
association with Pneumocystis Jirovecci pneumonia has
also been reported [8,14]. Chlamydia pneumonia serology
has been found positive in a patient with AFOP [15,16].
We would specially like to discuses AFOP’s association
with infection and describe the pattern of disease weencountered in this case. Our patient presented a picture
of community acquired pneumonia (CAP). Her CRP
and white cell counts were elevated with striking neu-
trophilia. These lab parameters normalized with antibiotic
therapy, however she still remained symptomatic. This
prompted us to consider bronchoscopy which the patient’s
family refused. To obtain a tissue diagnosis, a CT guided
biopsy of the lung lesion as visualized on HRCT was
performed which clinched the diagnosis. Such a pattern
of disease describing AFOP unmasked by treating a
suspected CAP has rarely been described. Thus, our
report emphasizes that AFOP should be considered in
the differentials of CAP unresponsive to standard antibiotic
therapy.
Our case has striking similarities to a few previous
cases which heralded such a diagnostic dilemma. These
patients with a suspected diagnosis of CAP did not
respond to antibiotic therapy, only to reveal AFOP on
biopsy and histopathology [15-17].
AFOP can produce an elevated ESR and CRP; however
a raised white cell count with striking neutrophilia is
most suggestive of a simultaneous bacterial infection
which also responded to antibiotic therapy. Though the
cultures did not reveal any organism, prospective studies
show that the cause of CAP is not identifiable in 40-60%
cases, thus cultures may be negative [18]. Previous
courses of antibiotics may also have contributed to nega-
tive culture results.
We would also like to discuss in the light of past
literature, the role of important diagnostic modalities we
used in obtaining diagnosis. HRCT provided valuable in-
put regarding the site of the lesions. Many different radio-
logical appearances of AFOP have been described in some
review articles. Beasely et al. and Lopez et al. described bi-
lateral “diffuse lung infiltrates” and “bilateral patchy lung
infiltrates” respectively, as the most common radiographic
abnormalities [1,6]. Our patient had generalized nodular
and interstitial infiltrates with dense consolidation and
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these findings have been described previously, they are less
common in AFOP, particularly the pattern of lung lobe or
complete lung consolidation [6,17].
Though we could not perform Bronchoscopy in this
case, our literature search showed that broncho alveolar
lavage (BAL) provided non specific and inconclusive find-
ings in AFOP in almost 100% cases. The only case where
it provided a breakthrough in diagnosis was when a trans
bronchial biopsy yielded a histological diagnosis [6].
Since AFOP is a histological diagnosis, a good tissue
sample is essential for examination. The most commonly
used methods to obtain a sample include video assisted
throacoscopic biopsy (VATS) in living patients and CT
guided biopsy. Trans bronchial biopsy has also been used
[6]. Histology is classic; the presence of intra alveolar fibrin
balls is the hallmark as shown in Figure 4. Organizing
pneumonia heralded by presence of proliferating fibroblas-
tic foci (Masson bodies) and type II pneumocyte hyperpla-
sia is also observed [1]. Unlike Diffuse alveolar damage,
hyaline membranes are absent [1]. These features are well
depicted by our photomicrographs.
Numerous treatment modalities have been used for
AFOP. The most common and successful has been
corticosteroids. Other agents successfully used include
cyclophosphamide, mycophenolate mofetil, azathioprine
and mechanical ventilation [6,16]. Different corticosteroid
dosages have been used. Our experience was to use intra-
venous methyl prednisolone 60 mg every 6–8 hourly
for the first 5 days followed by gradual tapering and
maintenance to a dose of 40 mg daily for 3 months. Un-
fortunately our patient did not comply with the treatmentFigure 4 Histopathology of the lung biopsy. Panel A shows multiple o
membrane formation. Variable areas of spindle cells fibroblastic proliferatio
being depicted by the black arrows in panel B.and relapsed, got readmitted and was managed on the
same regimen. Thus, we stress on the importance of ad-
herence to corticosteroid therapy for at least 3 months.
Relapse may also occur during tapering of steroids [2,19].
Conclusion
From this case we conclude, that AFOP is a rare clinical
pattern of lung injury and should be considered as a dif-
ferential in patients with suspected CAP unresponsive to
standard antibiotic therapy. Diagnosis is by biopsy and
histopathological examination of the obtained tissue.
Treatment is with corticosteroids; the response is dra-
matic and we stress on good compliance with treatment
since relapse can occur during tapering steroids or with
non compliance.
Numerous conditions have been described with AFOP.
Our case is distinct since we describe a pulmonary infec-
tion in association with AFOP with slightly atypical radio-
logical features and clinical course.
Finally, AFOP might represent an under diagnosed and
under reported condition, especially in the developing
countries. This may be due to the complicated means of
obtaining a tissue diagnosis which are not present in most
tertiary care settings of our region. Further studies are
needed to elucidate various clinical aspects of this interest-
ing pattern of lung injury.
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Akhtar and Abideen BMC Research Notes  (2015) 8:38 Page 6 of 6Abbreviations
AFOP: Acute fibrinous and organizing pneumonia; CT guided
biopsy: Computed tomography guided biopsy; HRCT: High resolution
computed tomography; VATS: Video assisted throacoscopic surgery;
CAP: Community acquired pneumonia.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AA was involved in making pivotal decisions regarding the patient’s
treatment while in the high dependency unit and on the pulmonology
floors. He was the primary physician of the patient. He reviewed the
manuscript critically and approved it for final submission. ZUA was the
resident who took care of the patient. He was involved in planning of
various investigations for the patient. He performed the literature review,
drafted the manuscript, reviewed it critically and approved it the end for
submission. He was also involved in retrieving high quality images for
publication from the pathology and radiology archives. Both authors read
and approved the final manuscript.
Acknowledgements
We would like to acknowledge Dr Samia Nawaz from the department of
pathology, Shifa International Hospital for helping us with the histopathological
images.
Author details
1Department of Pulmonology and Critical Care, Shifa International Hospital,
Islamabad, Pakistan. 2Resident Internal Medicine, Department of Internal
Medicine, Shifa International Hospital, Islamabad, Pakistan.
Received: 8 August 2014 Accepted: 15 January 2015
References
1. Beasley MB, Franks TJ, Galvin JR, Gochuico B, Travis WD. Acute fibrinous and
organizing pneumonia: a histological pattern of lung injury and possible
variant of diffuse alveolar damage. Arch Pathol Lab Med. 2002;126:1064–70.
2. Tzouvelekis A, Koutsopoulos A, Oikonomou A, Froudarakis M, Zarogoulidis P,
Steiropoulos P, et al. Acute fibrinous and organizing pneumonia: a case
report and review of the literature. J Med Case Reports. 2009;3:74.
3. Qiu YY, Miao LY, Cai HR, Xiao YL, Ye Q, Meng FQ, et al. The
clinicopthological features of acute fibrinous and organizing pneumonia.
Zhonghua Jie He He Hu Xi Za Zhi. 2013;36:425–30.
4. Cincotta DR, Sebira NJ, Lim E, Peters MJ. Fatal acute fibrinous and
organizing pneumonia in an infant: The histopathological variability of
acute respiratory distress syndrome. Pediatr Crit Care Med. 2007;8:378–82.
5. Prahalad S, Bohnsack JF, Maloney CG, Leslie KO. Fatal acute fibrinous and
organizing pneumonia in a child with juvenile dermatomyositis. J Pediatr.
2005;146:289–92.
6. López-Cuenca S, Morales-García S, Martín-Hita A, Frutos-Vivar F,
Fernández-Segoviano P, Esteban A. Severe acute respiratory failure
secondary to acute fibrinous and organizing pneumonia requiring
mechanical ventilation: a case report and literature review. Respir Care.
2012;57:1337–41.
7. Rapaka V, Hussain MA, Niazi M, Diaz-Fuentes G. Severe acute fibrinous and
organizing pneumonia causing acute respiratory distress syndrome and
shock. J Bronchology Interv Pulmonol. 2011;18:269–73.
8. Otto C, Huzly D, Huttel A, Benk C, Rieg S, Ploenes T, et al. Acute fibrinous
and organizing pneumonia associated with influenza A/H1N1 pneumonia
after lung transplantation. BMC Pulm Med. 2013;19(13):30.
9. Valim V, Rocha RH, Couto RB, Paixao TS, Serrano EV. Acute fibrinous and
organizing pneumonia and undifferentiated connective tissue disease:
a case report. Case Report Rheumatol. 2012;2012:549298.
10. Hariri LP, Unizony S, Stone J, Mino-Kenudson M, Sharma A, Matsubara O, et al.
Acute fibrinous and organizing pneumonia in systemic lupus erythematosus:
a case report and review of the literature. Pathol Int. 2010;60:755–9.
11. Sauter JL, Butnor KJ. Expanding the spectrum of pulmonary histopathologic
manifestations of anti-synthetase syndrome: Anti-EJ-associated acute fibrinous
and organizing pneumonia. Histopathology. 2014 [Epub ahead of print].12. Guimarães C, Sanches I, Ferreira C. Acute fibrinous and organising
pneumonia. BMJ Case Rep. 2012;20:2012.
13. Labrinas S, Gumy-Pause F, Rougemont AL, Baerlocher G, Leibundgut EO,
Porret N, et al. Is acute fibrinous and organizing pneumonia the expression
of immune dysregulation. J Pediatr Hematol Oncol. 2013;35:139–43.
14. Heo JY, Song JY, Noh JY, Yong HS, Cheong HJ, Kim WJ. Acute fibrinous and
organizing pneumonia in a patient with HIV and Pneumocystis jiroveci
pneumonia. Respirology. 2010;15:1259–61.
15. Ribera A, Llatjós R, Casanova A, Santin M. Chlamydia Pneumoniae infection
associated to acute fibrinous and organizing pneumonia. Enferm Infecc
Micribiol Clin. 2011;29:632–4.
16. Bhatti S, Hakeem A, Torrealba J, McMahon JP, Meyer KC. Severe acute
fibrinous and organizing pneumonia (AFOP) causing ventilatory failure:
successful treatment with mycophenolate mofetil and corticosteroids.
Respir Med. 2009;103:1764–7.
17. Mittal V, Kulshrestha R, Arya A, Bajaj P. Acute fibrinous and organizing
pneumonia presenting as complete lung consolidation. Singapore Med J.
2011;52:e88.
18. Chestnutt MS, Prendergast TJ, Tavan ET. Pulmonary disorders. In: Papadakis
MA, McPhee SJ, editors. Current Medical Diagnosis and treatment 2014.
New York: McGraw –Hill; 2014. p. 262.
19. Zhang J, Fang QH, Feng RE, Ma YM, Cao Y, Wang RG. Acute fibrinous and
organizing pneumonia: a case report and review of the literature.
Zhonghua Jie He He Hu Xi Za Zhi. 2010;33:892–5.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
